Blend Labs Exceeds Q1 Guidance, Reports Breakeven Non-GAAP EPS, and Repurchases $18.6M in Shares
BLND sits 23% above its 52-week low of $1.33.
Summary
Blend Labs, Inc. reported Q1 2026 financial results that exceeded guidance, achieving breakeven non-GAAP EPS and repurchasing $18.6 million in shares, indicating strong operational performance and shareholder value creation.
Key Events · Earnings and Guidance · BLND
-
Exceeded Q1 Guidance
Total revenue of $30.8 million and non-GAAP operating income of $4.1 million both came in above the high end of the company's guidance for the first quarter of 2026.
-
Improved Profitability
Non-GAAP diluted net loss from continuing operations attributable to common stockholders per share was breakeven ($0.00), an improvement from a $0.01 loss in Q1 2025. GAAP operating loss also improved to $5.1 million from $8.0 million year-over-year.
-
Significant Share Repurchase
The company repurchased 11.2 million shares for $18.6 million during the first quarter, with $31.4 million remaining on the existing $50 million authorization. This follows the program authorized on March 10, 2026.
-
Strong Q2 2026 Guidance
Blend Labs provided guidance for Q2 2026, projecting total revenue between $32.0 million and $34.0 million, and non-GAAP operating income between $5.5 million and $6.5 million.
Analysis · BLND · Technology
Blend Labs, Inc. delivered a strong first quarter, surpassing its own guidance for both revenue and non-GAAP operating income. The company achieved breakeven non-GAAP diluted net loss per share, signaling significant operational improvements and a positive trajectory towards profitability. Furthermore, the execution of its share repurchase program, with $18.6 million in shares bought back, demonstrates management's confidence in the company's valuation and commitment to returning capital to shareholders. This performance, coupled with a growing customer base and optimistic Q2 guidance, suggests continued momentum and could positively impact investor sentiment.
At the time of this filing, BLND was trading at $1.63 on NYSE in the Technology sector, with a market capitalization of approximately $421.7M. The 52-week trading range was $1.33 to $4.49. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.